tiprankstipranks
Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market

Orchestra BioMed Holdings (OBIO) Financial Statements

52 Followers

Orchestra BioMed Holdings Financial Overview

Orchestra BioMed Holdings's market cap is currently ―. The company's EPS TTM is $-1.46; its P/E ratio is -5.84; Orchestra BioMed Holdings is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 620.00K$ 262.00K$ 419.00K$ 728.00K$ 1.02M
Gross Profit$ 586.00K$ 401.00K$ 378.00K$ 915.00K$ 1.21M
EBIT$ -14.42M$ -12.48M$ -14.21M$ -13.05M$ 14.10M
EBITDA$ -14.35M$ -12.41M$ -15.01M$ -13.84M$ 13.31M
Net Income Common Stockholders$ -13.46M$ -12.82M$ -13.30M$ -12.05M$ 14.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 75.04M$ 87.59M$ 108.85M$ 117.77M$ 127.23M
Total Assets$ 82.63M$ 95.21M$ 116.36M$ 125.88M$ 136.28M
Total Debt$ 1.62M$ 1.69M$ 11.46M$ 11.60M$ 11.74M
Net Debt$ -73.41M$ -85.91M$ -97.39M$ -106.17M$ -115.50M
Total Liabilities$ 25.44M$ 27.17M$ 36.70M$ 36.44M$ 36.53M
Stockholders Equity$ 57.19M$ 68.04M$ 79.66M$ 89.44M$ 99.75M
Cash Flow-
Free Cash Flow$ -13.12M$ -10.97M$ -10.30M$ -10.69M$ -14.25M
Operating Cash Flow$ -13.11M$ -10.97M$ -10.28M$ -10.66M$ -14.21M
Investing Cash Flow$ 5.86M$ 33.15M$ 12.95M$ 8.12M$ -43.53M
Financing Cash Flow$ 18.00K$ -10.70M$ 4.00K$ 86.00K$ 56.82M
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

Orchestra BioMed Holdings Debt to Assets

Orchestra BioMed Holdings Cash Flow

Orchestra BioMed Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis